Australia's largest stock trading and investment forum Australia's #1 stock forum

GMV

0.00%

3.9¢ g medical innovations holdings limited

Top 20 List GMV, page-99

First 99 Last

Share
Profile

Follow
Glyco

6,165 Posts.

2345

26/03/18

14:42

Post #: 32028286
Share

Originally posted by Ruby15 ↑

Hi Glyco couldn't agree more that this share price is being targeted and manipulated to accommodate individuals and or companies.

From a shareholders prospectus, it is very annoying to see the SP rise on such good volume with excellent
movement and perfect charting to support a rally and then for it to be dragged back down again.

The last consolidation at the $0.295 level on Mar 1st saw the Buy/Sell support which was confirmed with a rally upwards to $0.38.

How or why does a share price give so many positive indicators only to be knee capped and spend the next 10 days plummeting back down, and below the previous low. This stock is not acting or performing the way a stock should once it has consolidated and started a positive trend upwards. We might as well just throw the baby out with the bath water and forget about normalised trading strategies.

The only reason that I feel comfortable holding this stock at the moment, is the fact that I have Long Term confidence with management and the opportunities that await this fantastic medical company.

I'm not sure if the number of shares on issue and the future number of shares to be issued have been raised. I think that the number of shares to be issued are going to dilute the value of the company going forward with regard to EPS.
It seems an awful lot of shares to be issued willy nilly for basically the staff doing what their paid for.

As previously mentioned, I have an enormous amount confidence in this company.
I have been doing day trading full time for the last 20 years and I have never, never, never seen a company such as GMV who have a mind boggling amount of future profits. Not only do they have MOU's in place for upwards of 1 billion in sales for the Prizma sleeve, but they also have future profits that will be generated from the Patch.
When you include the revenue from the patch once patients leave the hospital, the income stream will generates massive profits.

I can only see blue sky for this company once the CFDA issue the approval (end of Mar to mid Apr) for the GMV suite of products.
Hopefully we will see 2mths of revenue for this financial year and then a more accurate form of financials going forward.
This would provide a re-rating of the share price and then to top it all off, a profit upgrade somewhere close to Sept 2018 will send it into orbit.

Cheers

Expand

@Ruby15

Sources tell me some lawyers (& possibly ASIC) will be keeping a keen eye on every single share traded here.

(I prefer them to audit last 10 months history)

Cheers
G

GMV Price at posting: 31.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

HXL

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

Geochemical work at Newington picks up gold and copper anomalies for Midas